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Linear IgA bullous dermatosis (LABD) is an autoimmune skin 
disorder in which blisters form as a result of a split between the 
epidermis and dermis. The first cases of LABD date from 1901 - 1905, 
when it was still considered to be part of the spectrum of dermatitis 
herpetiformis. Only 80 years later was it recognised as a distinct 
clinical entity.[1]
IgA autoantibodies react to components of the hemidesmosomes 
and basement membrane.[2] The blisters are classically tense, 
indicating that they are of subepidermal origin as opposed to the 
flaccid bullous lesions of epidermal origin.[3]
The name LABD arises from the finding of a line of IgA antibodies 
below the epidermis on immunofluorescence examination of a skin 
biopsy specimen.[3]
Case report
A 3-year-old boy was brought to the emergency department at Lera-
tong Hospital, Johannesburg, South Africa, with a 1-week history 
of progressively worsening blisters on his arms and legs. He was 
unexposed to HIV and had previously been well, with no prior 
hospital admission.
Two weeks before the appearance of the rash, the patient had 
suffered from a fever and vomiting. His mother took him to a private 
general practitioner (GP), who prescribed cyclizine (an antiemetic), 
Goldgesic syrup (mainly paracetamol), amoxicillin plus clavulanic 
acid, and a co-trimoxazole suspension.
After the patient had been on the above treatment for about 
3 days, his mother noticed a rash comprising small blisters on 
his arms and legs. A different GP was consulted, who prescribed 
griseo fulvin, retapamulin ointment, Tetmosol soap, cloxacillin and 
chlorpheniramine maleate, with no advice to stop the previously 
prescribed drugs.
The rash got progressively worse, so when the mother took the 
child to a third GP, she was advised to take him to hospital.
On presentation to Leratong Hospital the patient was well, with 
vital signs within normal limits and no remarkable findings on 
systemic examination.
On examination of the skin, tense, deep bullae with surrounding 
vesicles on an erythematous base were present on the distal 
extremities. There were areas of central necrosis and a tendency to 
coalesce (Fig. 1). The mucous membranes were not involved and the 
palms and soles were spared. Around the left wrist and right lower 
limb, the lesions had formed a ‘string of pearls’ sign (Fig. 1). There 
This open-access article is distributed under 
Creative Commons licence CC-BY-NC 4.0.
A 3-year-old child was brought to the casualty department at Leratong Hospital, Johannesburg, South Africa, with severe bullous eruptions 
on the distal portions of both the upper and lower limbs. He had visited three different general practitioners prior to presentation and had 
been given several drugs and ointments, including three different classes of antibiotics. During his admission, the diagnosis of linear IgA 
bullous dermatitis was made. Dapsone and prednisone were given and he recovered well.
S Afr Med J 2017;107(7):578-580. DOI:10.7196/SAMJ.2017.v107i7.12407
CASE REPORT
Blistering rash in a young male child
C Sanders, MB ChB; H Potgieter, MD, FCPaed
Paediatrics Department, Leratong Hospital, Johannesburg, South Africa
Corresponding author: C Sanders (cathrynsand@gmail.com)
Fig. 1. The lesions on presentation, including the ‘string of pearls’ sign 
(white arrow).
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were a few smaller vesicular lesions on the lower abdomen and 
around the anus. The patient complained that the lesions were itchy, 
and the lesions around his anus were painful, making it difficult for 
him to pass a stool.
The patient was admitted and assessed as suffering from a possible 
drug reaction. All medication was stopped and he was referred to the 
Dermatology Department at Baragwanath Hospital for consultation 
and a biopsy.
The dermatologist’s differential diagnosis was LABD, followed by 
bullous erythema multiforme. The treatment given was a combination 
of prednisone and dapsone, as well as topical steroids and emollients 
to use on the affected areas. The patient responded well to treatment, 
with the lesions showing vast improvement after 1 week of the 
prescribed medication (Fig. 2).
The patient was followed up at the Leratong outpatient depart-
ment, and 6 months after the initial presentation the lesions had 
almost completely healed, with evidence of post-inflammatory 
hyperpigmentation (Fig. 3). Review of the histological findings and 
direct immunofluorescence examination confirmed the diagnosis of 
linear IgA bullous dermatosis, an intact skin punch biopsy showing 
1 - 2+ linear staining in the region of the epidermal basement mem-
brane.
Discussion
Linear IgA dermatosis is a rare autoimmune bullous disease, yet 
the most common autoimmune bullous disease in children.[1] The 
aetiological factor triggering the autoimmune mechanism of the 
disease is unknown.[1]
The typical clinical presentation of LABD is of small vesicles or 
bullae, which are annular and may develop into a target shape. There 
is a tendency for new vesicles to form in a ring around the old lesion, 
giving the ‘string of beads/pearls’ sign, which was present in our 
patient.
It may be difficult to distinguish LABD clinically from derma-
titis herpetiformis. They are both blistering diseases and on 
immunofluorescence microscopy show evidence of IgA deposition; 
however, dermatitis herpetiformis is associated with a gluten-sensi-
tive enteropathy (coeliac disease).[4]
The presentation of LABD can follow a viral illness or exposure to 
a drug. The most frequently associated drugs include vancomycin, 
diclofenac and co-trimoxazole, but the most consistent association 
described in the literature is with vancomycin.[1,3,5]
The diagnosis is made on examination of a skin biopsy specimen, 
where an infiltration of neutrophils and eosinophils is seen under 
the epidermis. Direct immunofluorescence examination reveals IgA 
along the basement membrane in a linear pattern.
Most cases reported in the literature had a similar outcome to 
that in our patient, complete remission being achieved following a 
course of prednisone and dapsone.[1] One such case report described 
a 10-month-old white child with LABD with a similar presentation to 
Fig. 2. Clinical improvement after 1 week’s treatment with prednisone and 
dapsone. 
Fig. 3. Almost complete healing 6 months after initial presentation.
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our patient, but with no fever or mucosal signs. However, in contrast 
to our case, there was no causal relationship with drug exposure or 
viral illness to explain the occurrence of the lesions.[1]
In a similar case report, where an infant developed LABD but 
failed to respond to prednisone, mycophenolic acid was used with 
a good clinical outcome.[6] This drug should be used with caution, 
however, as it can have adverse effects such as myelosuppression, 
infections and severe diarrhoea.
When dapsone is contraindicated, e.g. in patients with glucose-6-
phosphatase dehydrogenase deficiency, haemolytic anaemia or severe 
bone marrow suppression, LABD has been successfully treated with 
flucloxacillin with a decreased incidence of remission, provided the 
treatment was started early on in the course of the disease.[7]
Conclusion
This case illustrates the importance of knowing about LABD, the 
differ ential diagnosis of which includes bullous disease of childhood 
and erythema multiforme. It also highlights the danger of prescribing 
a ‘shopping list’ of drugs/antibiotics, which makes it difficult to 
identify the offending drug if an adverse drug reaction does develop. 
It also emphasises the importance of timeous referral to appropriate 
specialist support for early recognition, relevant special investigations 
and treatment of unusual clinical presentations.
Acknowledgements. None.
Author contributions.  Written by CS, with contributions from HP. 
Funding. None.
Conflicts of interest. None.
1. De Souza BC, Tebcherani A. Linear IgA bullous dermatosis: Report of an exuberant case. An Bras 
Dermatol 2013;88(6 Suppl 1):S67-S70. http://doi.org/10.1590/abd1806-4841.20132154
2. Burge S. Oxford Handbook of Medical Dermatology. 1st ed. London: Oxford, 2011.
3. DermNet New Zealand. Linear IgA bullous disease. 2015. www.dermnetnz.org/topics/linear-iga-
bullous-disease (accessed 11 November 2016).
4. Kirtschig G, Wojnarowska F. Autoimmune blistering diseases: An up-date of diagnostic methods and 
investigations. Clin Exp Dermatol 1994;19(2):97-112.  http://doi.org/10.3238/arztebl.2011.0405
5. Nousari HC, Kimyai-Asadi, A, Caeiro JP, et al. Clinical, demographic and immunohistological features 
of vancomycin induced linear IgA bullous disease of the skin: Report of two cases and review of the 
literature. Medicine (Baltimore) 1999;78(1):1-8.
6. Farley-Li J, Mancini A. Treatment of linear IgA bullous dermatosis of childhood with mycophenolate 
mofetil. Arch Dermatol 2003;139(9):1121-1124. http://doi.org/10.1001/archderm.139.9.1121
7. Alajlan A, Al-Khawajah M, Al-Sheikh O, et al. Treatment of linear IgA bullous dermatosis of 
childhood with flucloxacillin. J Am Acad Dermatol 2006;54(4):652-656. http://doi.org/10.1016/j.
jaad.2005.11.1102
Accepted 14 March 2017.
